6,678 trials
Pulmonary Embolism · Thoracic Surgery
Primary: Incidence of Postoperative Pulmonary Embolism (PE) in Surgical Thoracic Patients Under Currently Used PE Prevention Strategies. — 3 Participants
Onychomycosis
Primary: Percentage of Participants With at Least One Adverse Event — 39 Participants
HIV/AIDS · Substance Use Disorders · Adherence, Medication
Primary: Feasibility of Digital Pills to Measure PrEP Adherence — 411; 368; 320 Expected ingestions per pill counts
Healthy
Primary: Measurement of Maximum Serum Concentration of Lidocaine (Cmax) — 113.95; 123.54; 706.15 ng/ml
Impacted Third Molar Tooth
Primary: Postoperative Pain — 51.4; 56.3; 60.9 score on a scale
Seborrheic Dermatitis
Primary: Percent Change in ISGA (Investigator's Static Global Assessment) Score — 67.8 percent change
Insomnia
Primary: Within-person Change in ISI Score — -8.1; -5.6 score on a scale
Pharmacokinetics of Mirabegron · Food Effect · Healthy Chinese Subjects
Primary: Area Under The Concentration-Time Curve (AUC) From The Time of Dosing Extrapolated to Time Infinity (AUCinf) For Mirabegron — 81.8; 143; 263; 429 Hour*nanogram per…
Carcinoma, Basal Cell
Primary: The Number of Patients With a Score of 21 or Greater by the Visual Assessment Weighted Score (VAWS). — 34 Participants
Device Latency
Primary: Percentage of Participants With Accuracy of Ingestible Event Marker (IEM) Detection — 73.3; 63.3; 76.7; 93.3 percentage of participants
Metabolic Syndrome · Hypertriglyceridemia
Primary: Serum TG — 233; 157; 176; 156 mg/dl
Rheumatoid Arthritis
Primary: Disease Activity Score for 28-joint Counts (DAS28) — 5.7; 4.3 score on a scale
Traumatic Injury · Venous Thromboembolism
Primary: Initial AT-III Activity -- Control Group vs. Intervention Group Prior to Randomization — 87; 82 Percent AT-III activity (%) — p=0.092
Colorectal Disorders
Primary: Verbal Pain Scale (VRS) - 4 Week Post-op — 0.4; 1.1 score on a scale
Obese · Cigarette-smoking · Schizophrenia
Primary: Change From Baseline in Weight at 24 Weeks — 0.2; -0.9 kilogram